Thrombosis and cancer

KRAS-activating mutations: an independent risk factor for VTE?

Colorectal cancer (CRC) is the third most common type of cancer in Europe , after breast and prostate cancer, and...

Drug-drug interactions (DDIs) between anticoagulants (AC) and anticancer therapies present a significant concern in the...

Thanks to advances in both cancer and venous thromboembolism (VTE) management, the epidemiology of cancer-associated...

Cancer-associated thrombosis (CAT) poses a frequent and intricate challenge in the management of cancer patients,...

Cancer patients often experience life-threatening complications, such as cancer-associated thrombosis (CAT) and...

Artificial intelligence (AI)* refers to the field of computer science that uses powerful computers and large amounts of...

Thrombocytopenia, a low platelet count (<100 × 109/L), is a common side effect of cancer and its treatment. Its...

Neutrophils, the predominant white blood cells in humans, hold a vital function within the immune response by serving...

The relationship between cancer and thrombosis is a well-established and intricate interplay within the realm of...

Thrombophilia refers to a group of conditions where the blood has an elevated tendency to form clots. It can stem from...